'Management of a spoiled identity': systematic review of interventions to address self-stigma among people living with and affected by HIV
For pre-exposure prophylaxis (PrEP) to have a substantial public health impact, access to PrEP needs to be improved so that more people who would benefit from it receive PrEP. Services need to adapt and innovate. A series of recent articles, most of them published in a special issue of Sexual Health, outline a range of promising approaches.
MEASURE Evaluation’s PLACE method builds local capacity to find HIV-positive people who are not on treatment, who may not know their HIV status, and who therefore are at risk of infecting others. The HIV/AIDS epidemic is often concentrated among “key populations”—men who have sex with men, female sex workers, transgender people, and people who inject drugs. Sharon Weir, the senior technical advisor for key populations at MEASURE Evaluation—funded by the United States Agency for International Development and the U.S.
Key Populations: Evidence in Action webinar, "Strengthening local capacity for community-led responses to the HIV epidemic among key populations."
Please join us for the next installment in the Key Populations: Evidence in Action webinar series
DATE: Thursday, January 17, 2019
TIME: 9:00–10:30 am EST | 5:00-6:30 pm Nairobi | 9:00-10:30 pm Bangkok
Bibliography on Syndemics of HIV, STIs, TB, Hepatitis, Mental Health and Psychosocial Issues and Substance Abuse Among Key Populations
Introduction: Many studies have shown that key populations, including men who have sex with men, female sex workers, persons who inject drugs and transgender men and women face stigma, violence and discrimination as well as suffer from high rates of mental health/psychosocial issues and substance abuse. However, services to address these issues for key populations remain under resourced.
This two-part webinar series will share the findings from formative research (Part 1) and intervention research (Part 2) on the important topic of pre-exposure prophylaxis (PrEP), as presented by the Microbicide Product Introduction Initiative (MPii) at the HIV R4P conference satellite session.